Olash, Clayton
Buchanan, Derrick Matthew
Brown, Randi
Faerman, Afik
Cherian, Kirsten
Lin, George
Spiegel, David
Gross, James J.
Williams, Nolan
Article History
Received: 25 June 2025
Accepted: 6 January 2026
First Online: 31 January 2026
Competing interests
: N.R. Williams is a named inventor on Stanford-owned intellectual property relating to magnesium-ibogaine; he has served on scientific advisory boards for Otsuka, NeuraWell, Magnus Medical, Soneira, and Nooma as a paid advisor, and he has equity/stock options in NeuraWell, Soneira, and Nooma. N.R. Williams is listed as an inventor on U.S. provisional patent applications that cover some of the aspects reported here. All other authors report no financial relationships with commercial interests. The other authors have no relevant financial or non-financial interests to disclose.